Upstream Bio, Inc. Stock Analysis & AI Score
Upstream Bio, Inc. (UPB) has an ST Score of 39.6 (C), driven by its Financial Strength (A+) and held back by its Growth (D-). Analysts rate it Buy with a $25.00 price target (+786.5% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIUPB Stock Price History
UPB Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
UPB Latest Stock News
ST Score
Upstream Bio, Inc. (UPB) has an ST Score of 39.6 (C), driven by its Financial Strength (A+) and held back by its Growth (D-). Analysts rate it Buy with a $25.00 price target (+786.5% upside).
- Strongest
- Financial StrengthA+
- Weakest
- GrowthD-
All factor grades
- Financial StrengthA+
- ForecastA
- ProfitabilityC
- ValuationD+
- MomentumD-
- GrowthD-
- Piotroski2/9
Press Releases
Company Contact Details
UPB stock: frequently asked questions
What is UPB's ST Score?
Upstream Bio, Inc. (UPB) has an ST Score of 39.6 (C), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is UPB a buy, hold, or sell?
Analysts rate UPB a Buy, with a price target of $25.00 (+786.5% vs the current price). Our ST Score grades it C (39.6/100). The ST Score is a data-driven signal, not a recommendation.
What are UPB's factor grades?
Valuation D+, Profitability C, Financial Strength A+, Momentum D-, Growth D-, Forecast A.
What is UPB's valuation grade?
Upstream Bio, Inc. (UPB) earns a valuation grade of D+, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is UPB's growth grade?
Upstream Bio, Inc. (UPB) earns a growth grade of D-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is UPB's profitability grade?
Upstream Bio, Inc. (UPB) earns a profitability grade of C, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is UPB's financial strength grade?
Upstream Bio, Inc. (UPB) earns a financial strength grade of A+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for UPB?
The average analyst price target for Upstream Bio, Inc. (UPB) is $25.00 from 5 analysts, which is +786.5% versus the recent price of $2.82.
What is UPB's Piotroski score?
Upstream Bio, Inc. (UPB) has a Piotroski F-Score of 2 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.